Literature DB >> 34677673

Frequency and spectrum of glucokinase mutations in an adult Maltese population.

Nikolai Paul Pace1, Celine Ann Grech2, Barbara Vella2, Ruth Caruana3, Josanne Vassallo3.   

Abstract

AIM: To investigate the frequency and spectrum of glucokinase (GCK) mutations in a cohort of adults from an island population having a high prevalence of diabetes mellitus (DM).
METHODS: A single-centre cohort study was conducted, including 145 non-obese adults of Maltese-Caucasian ethnicity with impaired fasting glycaemia (IFG) or non-autoimmune diabetes diagnosed before the age of 40 years. Bidirectional sequencing of the GCK coding regions was performed. Genotype-phenotype associations and familial segregation were explored and the effects of missense variants on protein structure were evaluated using computational analysis.
RESULTS: Three probands with pathogenic/likely pathogenic GCK variants in the heterozygous state having clinical features consistent with GCK-diabetes were detected. The missense variants have structurally destabilising effects on protein structure. GCK variant carriers exhibited a significantly lower body mass index and serum triglyceride levels when compared to GCK variant non-carriers.
CONCLUSIONS: The frequency of GCK-diabetes is approximately 2% in non-obese Maltese adults with diabetes or prediabetes. This study broadens the mutational spectrum of GCK and highlights clinical features that could be useful in discriminating GCK-DM from type 2 DM or prediabetes. It reinforces the need for increased molecular testing in young adults with diabetes having a suspected monogenic aetiology.
© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.

Entities:  

Keywords:  Glucokinase; Hyperglycaemia; Monogenic diabetes; Prediabetes

Mesh:

Substances:

Year:  2021        PMID: 34677673     DOI: 10.1007/s00592-021-01814-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  38 in total

Review 1.  Impaired fasting glucose and impaired glucose tolerance: implications for care.

Authors:  David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.

Authors:  A L Gloyn; M van de Bunt; I M Stratton; L Lonie; L Tucker; S Ellard; R R Holman
Journal:  Diabetologia       Date:  2008-11-11       Impact factor: 10.122

3.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

4.  GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.

Authors:  David Carmody; Rochelle N Naylor; Charles D Bell; Shivani Berry; Jazzmyne T Montgomery; Elizabeth C Tadie; Jessica L Hwang; Siri Atma W Greeley; Louis H Philipson
Journal:  Acta Diabetol       Date:  2016-04-22       Impact factor: 4.280

5.  Glucokinase mutations in pediatric patients with impaired fasting glucose.

Authors:  C Aloi; A Salina; N Minuto; R Tallone; F Lugani; A Mascagni; O Mazza; M Cassanello; M Maghnie; G d'Annunzio
Journal:  Acta Diabetol       Date:  2017-07-19       Impact factor: 4.280

Review 6.  Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.

Authors:  Kara K Osbak; Kevin Colclough; Cecile Saint-Martin; Nicola L Beer; Christine Bellanné-Chantelot; Sian Ellard; Anna L Gloyn
Journal:  Hum Mutat       Date:  2009-11       Impact factor: 4.878

7.  Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Authors:  Gaya Thanabalasingham; Aparna Pal; Mary P Selwood; Christina Dudley; Karen Fisher; Polly J Bingley; Sian Ellard; Andrew J Farmer; Mark I McCarthy; Katharine R Owen
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

8.  Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness.

Authors:  Stepanka Pruhova; Petra Dusatkova; Pavel J Kraml; Michal Kulich; Zdena Prochazkova; Jan Broz; Jaroslav Zikmund; Ondrej Cinek; Michal Andel; Oluf Pedersen; Torben Hansen; Jan Lebl
Journal:  Int J Endocrinol       Date:  2013-09-11       Impact factor: 3.257

9.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

10.  Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia.

Authors:  Amanda Stride; Beverley Shields; Olivia Gill-Carey; Ali J Chakera; Kevin Colclough; Sian Ellard; Andrew T Hattersley
Journal:  Diabetologia       Date:  2013-10-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.